Novo Nordisk has told CNBC how it is preparing to go "all in" on launching its Wegovy pill outside the U.S, as the battle for dominance of the weight-loss market goes global. "When we launch, we'll go all in," Novo's Executive Vice President for International Operations, Emil Kongshøj Larsen, told CNBC in an interview on Tuesday. "It's a major opportunity." Novo announced last week that it expects to start the first launches outside of the U.S. later this year, pending approvals, after the pill